Cell Growth & Differentiation, Vol 9, Issue 9 767-776, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Role of mitogen-activated protein kinase in taxol-induced apoptosis in human leukemic U937 cells

CH Lieu, CC Liu, TH Yu, KD Chen, YN Chang and YK Lai
Department of Life Science, National Tsing Hua University, Hsinchu, Taiwan, Republic of China.

The induction of apoptosis by Taxol was investigated in human leukemic U937 cells. Treatment of U937 cells with 20 nM Taxol for 24 h induced apoptosis in 30-40% of cells, which resulted in an 80% growth inhibition 3 days after treatment. Synchronous cells at different cell cycle stages exhibited different sensitivities toward Taxol, and their reversion by certain protein kinase inhibitors was also phase specific. Kinetic studies of cell cycle progress reveal that Taxol accelerates the progression of the cell cycle, which facilitates the process of apoptosis, especially for cells initially in the G1 phase. This acceleration may result from transient activation of p42/ 44 mitogen-activated protein (MAP) kinase, because inhibition of upstream MAP/extracellular signal-regulated kinase kinase (MEK1/2) by PD98059 reversed this effect. However, the delayed S-G2-M-phase progression by PD98059 was insignificant. The results suggest that MAP kinase may not only mediate cell cycle progress but may also participate in the apoptosis pathway for cells originally in S phase.

This article has been cited by other articles:

				E. Azambuja, V. Durbecq, D. D. Rosa, M. Colozza, D. Larsimont, M. Piccart-Gebhart, and F. Cardoso HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer Ann. Onc., February 1, 2008; 19(2): 223 - 232. [Abstract] [Full Text] [PDF]

				E. S. Jeon, H. Y. Song, M. R. Kim, H. J. Moon, Y. C. Bae, J. S. Jung, and J. H. Kim Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK J. Lipid Res., March 1, 2006; 47(3): 653 - 664. [Abstract] [Full Text] [PDF]

				T.T.T. Nguyen, E. Tran, T.H. Nguyen, P.T. Do, T.H. Huynh, and H. Huynh The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells Carcinogenesis, May 1, 2004; 25(5): 647 - 659. [Abstract] [Full Text] [PDF]

				D. J. Taxman, J. P. MacKeigan, C. Clements, D. T. Bergstralh, and J. P-Y. Ting Transcriptional Profiling of Targets for Combination Therapy of Lung Carcinoma with Paclitaxel and Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase Inhibitor Cancer Res., August 15, 2003; 63(16): 5095 - 5104. [Abstract] [Full Text] [PDF]

				G. H. Yoo, M. P. Piechocki, J. F. Ensley, T. Nguyen, J. Oliver, H. Meng, D. Kewson, T. Y. Shibuya, F. Lonardo, and M. A. Tainsky Docetaxel Induced Gene Expression Patterns in Head and Neck Squamous Cell Carcinoma Using cDNA Microarray and PowerBlot Clin. Cancer Res., December 1, 2002; 8(12): 3910 - 3921. [Abstract] [Full Text] [PDF]

				H. M. McDaid and S. B. Horwitz Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines Mol. Pharmacol., August 1, 2001; 60(2): 290 - 301. [Abstract] [Full Text] [PDF]

				C. Yu, S. Wang, P. Dent, and S. Grant Sequence-Dependent Potentiation of Paclitaxel-Mediated Apoptosis in Human Leukemia Cells by Inhibitors of the Mitogen-Activated Protein Kinase Kinase/Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., July 1, 2001; 60(1): 143 - 154. [Abstract] [Full Text]

				P. Dent and S. Grant Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783. [Full Text]

				M. V. Blagosklonny, P. C. Bishop, R. Robey, T. Fojo, and S. E. Bates Loss of Cell Cycle Control Allows Selective Microtubule-active Drug-induced Bcl-2 Phosphorylation and Cytotoxicity in Autonomous Cancer Cells Cancer Res., July 1, 2000; 60(13): 3425 - 3428. [Abstract] [Full Text]

				T. Ohigashi, M. Ueno, S. Nonaka, T. Nakanoma, Y. Furukawa, N. Deguchi, and M. Murai Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells Am J Physiol Cell Physiol, January 1, 2000; 278(1): C66 - C72. [Abstract] [Full Text] [PDF]

				J.-i. Okano and A. K. Rustgi Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery J. Biol. Chem., May 25, 2001; 276(22): 19555 - 19564. [Abstract] [Full Text] [PDF]